This page shows Medicale (MCLE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
For every $1 of reported earnings, Medicale generates $0.56 in operating cash flow (-$23K OCF vs -$41K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Medicale earns $-4.5 in operating income for every $1 of interest expense (-$33K vs $8K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Medicale reported -$41K in net income in fiscal year 2025. This represents an increase of 29.3% from the prior year.
Medicale earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
Medicale held $0 in cash against $0 in long-term debt as of fiscal year 2025.
Medicale had 6M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
MCLE Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $3K0.0% | $3K | N/A | $4K-43.0% | $6K-58.2% | $15K | N/A | $9K |
| Operating Income | $3K+200.0% | -$3K | N/A | -$4K+43.0% | -$6K+58.2% | -$15K | N/A | -$9K |
| Interest Expense | $2K0.0% | $2K | N/A | N/A | N/A | $2K | N/A | N/A |
| Income Tax | N/A | $0 | N/A | $0 | $0 | $0 | N/A | $0 |
| Net Income | $5K+200.0% | -$5K | N/A | -$6K+33.2% | -$8K+50.4% | -$17K | N/A | -$10K |
| EPS (Diluted) | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A | $0.00 |
MCLE Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | $0 | $0 | $0 | $0-100.0% | $1590.0% | $1590.0% | $159 |
| Current Assets | N/A | $0 | $0 | $0 | $0-100.0% | $1590.0% | $1590.0% | $159 |
| Cash & Equivalents | N/A | $0 | $0 | $0 | $0-100.0% | $1590.0% | $1590.0% | $159 |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | N/A | $145K+3.8% | $140K+8.2% | $129K+4.5% | $124K+7.0% | $116K+16.8% | $99K+20.5% | $82K |
| Current Liabilities | N/A | $32K-4.3% | $34K+14.3% | $29K+13.5% | $26K+16.9% | $22K+43.1% | $16K+9.7% | $14K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | N/A | -$145K-3.8% | -$140K-8.2% | -$129K-4.5% | -$124K-7.2% | -$116K-16.9% | -$99K-20.6% | -$82K |
| Retained Earnings | N/A | -$222K-2.4% | -$217K-5.2% | -$206K-2.8% | -$201K-4.3% | -$193K-9.5% | -$176K-10.6% | -$159K |
MCLE Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7K+200.0% | -$7K-4.4% | -$6K-219.5% | -$2K+55.4% | -$5K+54.7% | -$10K+35.5% | -$16K-67.0% | -$9K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $7K0.0% | $7K+4.4% | $6K+219.5% | $2K-53.8% | $4K-56.3% | $10K-35.5% | $16K+67.0% | $9K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MCLE Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | -10490.6% | N/A | -6579.3% |
| Current Ratio | N/A | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.010.0 | 0.010.0 | 0.01 |
| Debt-to-Equity | N/A | -1.000.0 | -1.000.0 | -1.000.0 | -1.000.0 | -1.000.0 | -1.000.0 | -1.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$140K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is Medicale profitable?
No, Medicale (MCLE) reported a net income of -$41K in fiscal year 2025.
What is Medicale's operating cash flow?
Medicale (MCLE) generated -$23K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Medicale's total assets?
Medicale (MCLE) had $0 in total assets as of fiscal year 2025, including both current and long-term assets.
What is Medicale's current ratio?
Medicale (MCLE) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Medicale's debt-to-equity ratio?
Medicale (MCLE) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Medicale's cash runway?
Based on fiscal year 2025 data, Medicale (MCLE) had $0 in cash against an annual operating cash burn of $23K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Medicale's debt-to-equity ratio negative or unusual?
Medicale (MCLE) has negative shareholder equity of -$140K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Medicale's earnings high quality?
Medicale (MCLE) has an earnings quality ratio of 0.56x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Medicale cover its interest payments?
Medicale (MCLE) has an interest coverage ratio of -4.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.